GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers

NCT01118975 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped Lost sponsorship for study drug

Conditions

Breast Cancer
Neoplasm Metastasis

Interventions

DRUG: Vorinostat
DRUG: Lapatinib

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]